← All stocks

Denali Therapeutics Inc.

DNLI Net selling
CIK 0001714899 #1526 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.30M
$326.81K on a plan · $0.00 straight out of an exercise
Sold at will
$973.36K
4 of 7 sales
Net
−$1.30M
−$973.36K against sales at will

By person

14 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Watts Ryan J.
President and CEO
$580.77K (1)
−$580.77K
2,417,217
1.51%
$53.88M
−0.9%
Schuth Alexander O.
COFO and Secretary
$420.60K (3)
−$420.60K
802,744
0.5022%
$17.89M
+13.9%
Thornberry Nancy
Director
$261.93K (2) scheduled
−$261.93K
19,686
0.0123%
$438.80K
+5.4%
Chin Peter Scott
Chief Medical Officer
$36.87K (1)
−$36.87K
204,538
0.1280%
$4.56M
−0.8%
BAKER BROS. ADVISORS LP entity
Director
3,422,366
2.14%
$76.28M
+1.0%
Tessier-Lavigne Marc
Director
1,886,576
1.18%
$42.05M
+0.3%
Ho Carole
Chief Medical Officer
216,585
0.1355%
$4.83M
+82.3%
SATO VICKI L
Director
107,976
0.0675%
$2.41M
−6.2%
Krognes Steve E.
Director
38,202
0.0239%
$851.52K
−57.1%
Klein Peter S
Director
33,941
0.0212%
$756.54K
+57.9%
Cook Jennifer E.
Director
32,483
0.0203%
$724.05K
+62.1%
FLATLEY JAY T
Director
22,628
0.0142%
$504.38K
+122.2%
Schenkein David P
Director
21,665
0.0136%
$482.91K
+0.8%
Van Hauwermeiren Timothy
Director
17,040
0.0107%
$379.82K
Insider
Date
Role
Action
Shares
Price
Amount
Thornberry Nancy
2 Sep 2026
Director
Sold on a plan
615
$23.74
$14.60K
Thornberry Nancy
2 Sep 2026
Director
Sold on a plan
10,824
$22.85
$247.33K
Schuth Alexander O.
1 Sep 2026
COFO and Secretary
Sold on a plan
2,768
$23.44
$64.88K

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 237,184
History held since 8 Dec 2017